Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome

Journal of Clinical Epidemiology

Volumn 49, Issue 11, 1996, Pages 1253-1258

  Phillips, Andrew N ^a   Lazzarin, Adriano ^b   Gonzales Lahoz, Juan ^c   Clumeck, Nathan ^d   Glauser, M P ^e   Proenca, R ^f   Banhegyi, D ^g   Pedersen, Court ^h   Lundgren, Jens D ^h   Johnson, Anne M ⁱ  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f HOSPITAL CURRY CABRAL   (Portugal)

^g SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^h HVIDOVRE HOSPITAL   (Denmark)

ⁱ ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

AIDS defining diseases; CD4 lymphocytes; Europe; HIV

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; EUROPE; FEMALE; HISTOPLASMOSIS; HUMAN; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RETINITIS; TUBERCULOSIS; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0030297559     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(96)00216-8     Document Type: Article

References (25)

1. 1. Lane HC, Masur H, Gelmann EP, et al. Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. Am J Med 1985; 78: 417-422.
2. 2. Eyster E, Gail MH, Ballard JO, Al-Mondhiry H, Goedert JJ. Natural history of human immunodeficiency virus infections in haemophiliacs: Effects of T-Cell subsets, platelet counts, and age. Ann Intern Med 1987; 107: 1-6.
3. 3. Goedert JJ, Kessler CM, Aledort LM, et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with haemophilia. N Engl J Med 1989; 321: 1141-1148.
4. + lymphocyte counts and the development of AIDS. Lancet 1991; 337: 389-392.
5. + counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 1989; 111: 223-231.
6. + lymphocyte count as determinant of the time from HIV seroconversion to AIDS and death from AIDS: Evidence from the Italian Seroconversion Study. AIDS 1994; 8: 1299-305.
7. 7. MAP workshop. Stat Med 1993; 12: 2061-2126.
8. + lymphocyte end-points and AIDS in cohorts of homosexual men. AIDS 1993; 7: 1325-1329.
9. 9. Munoz A, Schrager LK, Bacellar H, et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991. Am J Epidemiol 1993; 137: 423-438.
10. + lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 1991; 4: 770-776.
11. + lymphocyte counts at AIDS manifestation in Germany from 1986 to 1991. AIDS 1992; 6: 413-420.
12. 12. van Leeuwen R, van den Hurk PHJ, Mulder JW, et al.. Opportunistic infections as measure of immunodeficiency in human immunodeficiency virus (HIV) infection. In: Janossy G, Autran B, Miedema F, Eds. Immunodeficiency in HIV-1 Infections and AIDS. EC/FERS/MRC Workshop on Immunodeficiency in HIV-1 Infections, Windsor, Surrey, 1991. Basel: Karger; 1992.
13. 15. Pedersen C, Gerstoft J, Tauris P, Lundgren JD, Gøtzsche PC, Buhl M, Salim Y, Schmidt K. Opportunistic infections and malignancies in 231 Danish AIDS patients. AIDS 1990; 4: 233-238.
14. + lymphocytes and opportunistic infections and neoplasms in patients with the human immunodeficiency virus. Med Clin (Barc) 1994; 102: 556-570.
15. 15. Phillips AN, Elford J, Sabin C, Bofill M, Janossy G, Lee CA. Immunodeficiency and the risk of death in HIV infection. JAMA 1992; 268: 2662-2666.
16. + and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol 1992; 88: 243-252.
17. + T lymphocytopenia. Ann Intern Med 1993; 119: 55-62.
18. 18. Lundgren JD, Pedersen C, Clumeck N, et al. Survival differences in European AIDS patients 1979-1989. Br Med J 1994; 308: 1068-1073.
19. 19. Centers for Disease Control. Classification system for human-T-lymphotropic virus type III/lymphadenopathy associated virus infections. MMWR 1986; 35:334-339.
20. 20. Choi S, Lagakos SW, Schooley RT, Volberding PA. CD4 lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann Intern Med 1993; 118: 674-680.
21. 21. Hoover DR, Saah AJ, Bacellar H, Phair J, Detels R, Anderson R, Kaslow RA. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. New Engl J Med 1993; 329: 1922-1926.
22. 22. Phillips AN, Antunes F, Stergious G, et al. A sex comparison of rates of new AIDS defining disease and death in 2554 AIDS cases. AIDS 1994; 8: 831-835.
23. 23. Whitmore-Overton SE, Tillett HE, Evans BG, Allardice GM. Improved survival from diagnosis of AIDS in adult cases in the United Kingdom and bias due to reporting delays. AIDS 1993; 7: 415-420.
24. + T-cell counts. J Acquir Immune Defic Syndr 1991; 4: 970-975.
25. 25. Gordin F, Masur H. Prophylaxis of Mycobacterium avium complex bacteremia in patients with AIDS. Clin Infect Dis 1994; 18(Suppl. 3): 223-226.